GLP-1 receptor agonists are injectable medications that mimic the effects of the naturally occurring hormone GLP-1 to lower blood sugar levels in people with type 2 diabetes. They work by stimulating the production and release of insulin from the pancreatic beta cells. Common brand names include Victoza, Ozempic, Rybelsus, Trulicity and Wegovy.

The global GLP-1 receptor agonist market is estimated to be valued at US$ 14319.85 Mn in 2023 and is expected to exhibit ... Read more

The GLP-1 receptor agonist drugs are increasingly adopted for treating type 2 diabetes owing to their efficacy and safety profile. GLP-1 receptor agonists help control blood sugar levels by stimulating the release of insulin from the pancreas. They mimic the effects of the naturally occurring incretin hormone GLP-1, which is released in response to eating by signaling the pancreas to release the right amount of insulin to regulate blood sugar. These drugs are also associated with weight loss ... Read more